drugset / Trial / NCT04536805
Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin
Non-randomizedSequentialOpen-labelTreatment
Summary
This phase I/II escalation dose study is assessing the efficacy of the recommended dose of stereotactic re-irradiation (SBRT) of relapses within the prostatectomy bed, potentiated by metformin
Timeline
- Start
- 2020-11-17
- Primary completion
- 2031-11
- Completion
- 2031-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 1700 mg | Oral |